Furthermore, plasma NfL has been proven to be useful in predicting clinical progression and conversion from MCI to dementia, with significantly lower concentrations observed in stable MCI patients compared to those progressing to AD [23,28,29]. The gene discussed is NEFL; the disease is Alzheimer disease.